<code id='325267858F'></code><style id='325267858F'></style>
    • <acronym id='325267858F'></acronym>
      <center id='325267858F'><center id='325267858F'><tfoot id='325267858F'></tfoot></center><abbr id='325267858F'><dir id='325267858F'><tfoot id='325267858F'></tfoot><noframes id='325267858F'>

    • <optgroup id='325267858F'><strike id='325267858F'><sup id='325267858F'></sup></strike><code id='325267858F'></code></optgroup>
        1. <b id='325267858F'><label id='325267858F'><select id='325267858F'><dt id='325267858F'><span id='325267858F'></span></dt></select></label></b><u id='325267858F'></u>
          <i id='325267858F'><strike id='325267858F'><tt id='325267858F'><pre id='325267858F'></pre></tt></strike></i>

          knowledge

          knowledge

          author:entertainment    Page View:85
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Listen: Biogen's situation, Wegovy's risks, & biotech insider trading
          Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

          SammyKimballforSTATWhydoCEOstalklikethat?Dobiotechstocktipsmakegoodgifts?AndwhatdoAnthonyFauciandSté

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          CZI to create biohub to build anti

          PriscillaChanandMarkZuckerbergappearvirtuallyatthe2023STATSummit.STATMetafounderMarkZuckerbergandhis